About Divisione di Ematologia Ospedale A. Perrino
Clinical Trials at Divisione di Ematologia Ospedale A. Perrino
During the past decade, Divisione di Ematologia Ospedale A. Perrino conducted 6 clinical trials. In the 10-year time frame, 6 clinical trials started and 0 clinical trials were completed, i.e. on
average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0%
of trials that started reached the finish line.
Clinical Trials Sponsors and Collaborators
In terms of collaborators to trials, out of the total clinical trials conducted in "Divisione di Ematologia Ospedale A. Perrino"
#1 collaborator was "Azienda Ospedaliera V. Cervello" with 1 trials as a collaborator, "Azienda Ospedaliera Villa Sofia" with 1 trials as a collaborator, "European Organisation for Research and Treatment of Cancer - EORTC" with 1 trials as a collaborator, "Istituto Clinico Humanitas" with 1 trials as a collaborator and "Ospedale "Perrino" Brindisi" with 1 trials as a collaborator. Other collaborators include -1 different institutions and companies that were
collaborators in the rest 9 trials.
Clinical Trials Conditions at Divisione di Ematologia Ospedale A. Perrino
According to Clinical.Site data, the most researched conditions in "Divisione di Ematologia Ospedale A. Perrino" are
"Acute Lymphoblastic Leukemia" (2 trials), "Acute Myeloid Leukemia" (2 trials), "Leukemia" (2 trials), "Thalassemia Intermedia" (2 trials) and "Thalassemia Major" (2 trials). Many other conditions were trialed in "Divisione di Ematologia Ospedale A. Perrino" in a lesser frequency.
Clinical Trials Intervention Types at Divisione di Ematologia Ospedale A. Perrino
Most popular intervention types in "Divisione di Ematologia Ospedale A. Perrino" are "Drug" (9 trials), "Other" (7 trials) and "Procedure" (1 trials). Other intervention types were less common.
The name of intervention was led by "Allogeneic SCT or Autologous SCT" (1 trials), "BEAM" (1 trials), "Blinatumomab" (1 trials), "Chemotherapy + Blinatumomab" (1 trials) and "Cycle 1 Induction" (1 trials). Other intervention names were less common.
Clinical Trials Genders at Divisione di Ematologia Ospedale A. Perrino
The vast majority of trials in "Divisione di Ematologia Ospedale A. Perrino" are
18 trials for "All" genders.
Clinical Trials Status at Divisione di Ematologia Ospedale A. Perrino
Currently, there are NaN active trials in "Divisione di Ematologia Ospedale A. Perrino".
undefined are not yet recruiting,
2 are recruiting,
3 are Active, not recruiting,
and undefined are Enrolling by invitation.
In total, there were 8 completed trials in Divisione di Ematologia Ospedale A. Perrino,
undefined suspended trials,
and 2 terminated clinical trials to date.
Out of the total trials that were conducted in Divisione di Ematologia Ospedale A. Perrino, 0 "Phase 1"
clinical trials were conducted, 6 "Phase 2" clinical
trials and 1 "Phase 3" clinical trials were conducted as
well. "Phase 4" trials included 0 trials, and there were
also 2 trials that are defined as “Not Applicable".